May 19, 2020 / 12:32 PM / 12 days ago

BRIEF-Shanghai Henlius Biotech Updates On Supplemental Applications For New Indications Of Hlx01

May 19 (Reuters) - Shanghai Henlius Biotech Inc:

* UNIT RECENTLY GOT “ACCEPTANCE NOTICE” OF SUPPLEMENTAL APPLICATIONS FOR NEW INDICATIONS OF HLX01 FROM NMPA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below